Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA
Engage Bio developed a platform technology that enables non-viral delivery of DNA to cells. The…
Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA
Engage Bio developed a platform technology that enables non-viral delivery of DNA to cells. The acquisition is the latest in a series of Eli Lilly deals that expand the pharmaceutical company’s pipeline and capabilities in genetic medicines. The post Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA…
MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO
Jason Prestinario talks about the state of healthcare interoperability today, while also addressing questions about the interoperability lawsuits he and others are involved in against Epic. The post MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO appeared first on MedCity News.
Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update
This analysis updates prior work that assessed the association between PEPFAR investments and several health indicators, beyond HIV. It finds that PEPFAR continues to be associated with significant improvement in these broader health gains, suggesting a spillover effect beyond the program’s HIV focus.
Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update
This analysis updates prior work that assessed the association between PEPFAR investments and economic and educational outcomes. It finds that PEPFAR continues to be associated with significant improvement in these broader areas, suggesting a spillover effect beyond the program’s HIV and health focus.
When the Referee Owns the Team — and Tennessee Changes the Rules
At the center of this issue is a simple question: should the entities responsible for managing prescription drug benefits also own the pharmacies that profit from those decisions? The post When the Referee Owns the Team — and Tennessee Changes the Rules appeared first on MedCity News.
How AI & CMS are Solving the $4 Trillion Healthcare Crisis
The message to the industry is clear: If your business model is optimized only for FFS, you are the legacy. The future of healthcare belongs to those who can trade hours spent for improved patient lives. The post How AI & CMS are Solving the $4 Trillion Healthcare Crisis appeared first on MedCity News.
Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier
As decentralized trials reduce face time with participants, sponsor organizations that treat engagement as an afterthought will pay for it in dropout rates, missing data and failed endpoints. The post Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier appeared first on MedCity News.
Watch: The Tug-of-War Over Taxpayer Dollars
Julie Rovner, KFF Health News’ chief Washington correspondent and host of the What the Health? podcast, recently spoke with Sen. Tammy Baldwin (D-Wis.) about the ongoing fight between President Donald Trump and Congress over control of federal spending. Baldwin, who is a member of the Senate Appropriations Committee and the Senate Health, Education, Labor and…
Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
SANDPOINT, Idaho — An anti-abortion pregnancy center on the outskirts of this Idaho Panhandle town greets visitors with an abridged Bible verse painted on the wall of its waiting area: “Come to me & I will give you rest.” 7B Care Clinic has been operating in Sandpoint since 2001 and was previously called Life Choices…
Dor Skuler, Intuition Robotics: Meet EllieQ
Dor Skuler is CEO of Intuition Robotics the maker of EllieQ — a remarkable AI robot that is a companion for seniors. I had a lot of fun meeting ElliQ and asking Dor about how she works. This is a wide-ranging interview with Dor and with EllieQ. She tells us about Florence Nightingale, what Dor…
